Universal American (UAM) Stock Price, News & Analysis

Company Overview

Universal American Corp. provides an array of health insurance and managed care products and services to people covered by Medicare. The Company's segments include Medicare Advantage, Management Services Organization (MSO), and Corporate & Other. The Medicare Advantage segment contains the operations of its initiatives in managed care for seniors. It operated 16 Medicare Shared Saving Program Accountable Care Organizations (ACOs) and two Next Generation ACOs, which included approximately 5,200 participating providers with approximately 221,800 assigned Medicare fee-for-service beneficiaries, as of December 31, 2016. The MSO segment supports its physician partnerships in the development of healthcare models, such as ACOs, with a range of capabilities and resources, including technology, analytics, clinical care coordination, regulatory compliance and program administration. It has developed a primary care physician alignment strategy, which is branded as The Healthy Collaboration.

Key Stats

• Today's Range: $9.97 to $9.97
• 50-Day Range: N/A
• 52-Week Range: $6.72 to $10.13
• Volume: N/A
• Average Volume: 271,199 shs
• Market Capitalization: N/A
• P/E Ratio: 31.16
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UAM Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Universal American own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Universal American investors own include EOG Resources (EOG), Endologix (ELGX), Immunomedics (IMMU), Novavax (NVAX), Orexigen Therapeutics (OREX), Pernix Therapeutics (PTX) and Synergy Pharmaceuticals (SGYP).

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: N/A
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:UAM
• CIK: 1514128
• Web: www.universalamerican.com
• Phone: +1-914-5972900
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 31.16
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A